MONTREAL, Jan. 29, 2018 /CNW Telbec/ - BioAmber
Inc. (NYSE: BIOA) (TSX: BIOA) - a leader in renewable materials, is pleased to announce the results of an independent
commercial trial conducted with a leading North American feed formulator, on the effectiveness of BioAmber's Bio-Succinic Acid,
BIO-SA™, as an ingredient in Animal Feed for nursery pigs.
In a commercial study co-sponsored by BioAmber, BIO-SA™ feed supplementation demonstrated substantial benefits towards the
growth performance and gut health in nursery pigs under dietary and environmental challenges. Specifically, the addition of
bio-succinic acid to feed resulted in material increases in the average daily weight gain of nursery pigs. In another series
of studies, in vitro tests have confirmed that BIO-SA™ exhibits antimicrobial activity against certain microorganisms at
lower concentrations than other organic acids. Results obtained by BioAmber indicate that BIO-SA™ in feed additives could improve
overall growth performance and reduce detrimental animal health conditions.
Succinic acid is listed by The Association of American Feed Control Officials (AAFCO) and the European Union Register of Feed
Additives, for immediate use in animal feed formulations.
BioAmber CEO Richard Eno stated, "Animal feed represents an extremely large market opportunity
for BioAmber, and these studies show that our product could play an important role in antibiotic replacement. BIO-SA™ can assist
the Animal Feed industry's continued move away from antibiotics as well as its ongoing drive for enhanced feed productivity,
while at the same time improving the overall sustainability of the supply chain. Formulation and early stage market testing
continues as we move towards ongoing, commercial sales in this important sector."
BioAmber will be attending the International Production & Processing Expo (IPPE), the world's largest annual poultry, feed
and meat technology exposition, in Atlanta, GA from January 30 through
February 1, 2018. Please contact Paul Petersen – Vice President of Sales at paul.petersen@bio-amber.com for more information.
About BioAmber
BioAmber (NYSE: BIOA, TSX: BIOA) is a renewable materials company. Its innovative technology platform combines
biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of
everyday products including plastics, paints, textiles, food additives and personal care products. For more information visit
www.bio-amber.com
Forward-Looking Statements
This press release contains forward-looking statements, which are subject to substantial risks, uncertainties and
assumptions. These statements often include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate,"
"seek," "will," "may" or similar expressions. Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee that the events and circumstances reflected in the forward-looking statements will
be achieved or occur and the timing of events and circumstances and actual results could differ materially from those projected
in the forward- looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. All
such statements speak only as of the date made, and we undertake no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise. For additional disclosure regarding these and
other risks faced by BioAmber, see disclosures contained in BioAmber's public filings with the SEC, including the "Risk Factors"
section of BioAmber's Annual Report on Form 10-K and the most recent quarterly report on Form 10-Q.
SOURCE BioAmber Inc.
View original content: http://www.newswire.ca/en/releases/archive/January2018/29/c3883.html